Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00506077
Show Display Options
Rank Status Study
1 Completed
Has Results
MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)
Condition: Paranoid Schizophrenia
Interventions: Drug: MK0249;   Drug: Comparator: Placebo (unspecified)

Indicates status has not been verified in more than two years